AI Genomics
Total Trials
3
As Lead Sponsor
0
As Collaborator
Total Enrollment
355
NCT04589312
Maternal Pertussis Wholecell Responses
Phase: Phase 2
Role: Collaborator
Start: Oct 21, 2020
Completion: Jun 30, 2023
NCT05231369
Safety and Immunogenicity of ChulaCov19 BNA159 mRNA Vaccine
Phase: Phase 1
Start: Dec 14, 2022
Completion: Jul 1, 2023
NCT05605470
Immunogenicity and Safety of ChulaCov19 BNA159 and ChulaCov19 BNA159.2 Vaccines as a Booster Dose in Adults
Start: Jan 19, 2023
Completion: Nov 18, 2024
Loading map...